<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>57</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2019</Year>
        <Month>05</Month>
        <Day>13</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis</title>
    <FirstPage>180</FirstPage>
    <LastPage>183</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Boostani</LastName>
        <affiliation locale="en_US">Department of Neurology, Quaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Pouran</FirstName>
        <LastName>Layegh</LastName>
        <affiliation locale="en_US">Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Javad</FirstName>
        <LastName>Yazdanpanah</LastName>
        <affiliation locale="en_US">Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Vosoughi</LastName>
        <affiliation locale="en_US">Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Mohammadi</LastName>
        <affiliation locale="en_US">School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Noseibe</FirstName>
        <LastName>Joneidi</LastName>
        <affiliation locale="en_US">Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reyhaneh</FirstName>
        <LastName>Bazargani</LastName>
        <affiliation locale="en_US">Research Center of Iranian Blood Transfusion Organization, Khorasan Razavi, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Delaram</FirstName>
        <LastName>Sayadpour Zanjani</LastName>
        <affiliation locale="en_US">Research Center of Iranian Blood Transfusion Organization, Khorasan Razavi, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Ebrahimzadeh</LastName>
        <affiliation locale="en_US">Department of Biostatistics and Epidemiology, Health Sciences Research Center, School of Health, Mashhad University of Medical Sciences Mashhad, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>12</Month>
        <Day>19</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Dermatologic manifestations are common in patients infected with HTLV-1 infection. In this study, we evaluated the dermatologic lesions associated with HAM/TSP patients in Mashhad, Iran. Dermatological findings of 37 patients with HAM/TSP were investigated and compared with those of an HTLV-1 negative control group. A cutaneous biopsy was performed as needed, and the results were statistically analyzed. Results of the present study showed that 34 cases with HAM/TSP (91.9%) and 24 cases in the control group (64.9%) had at least one skin lesion or history of skin lesion before (P=0.010). Xerosis was found in 22 persons (59.5%) in the case group and 4 persons in the control group (10.8%) (P=0.000). Only xerosis was significantly associated with HAM/TSP. Skin manifestations were quite frequent in patients with HAM/TSP. Xerosis was significantly associated with HAM/TSP.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/7222</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/7222/5234</pdf_url>
  </Article>
</Articles>
